» Articles » PMID: 14981092

Regulation of Ras-MAPK Pathway Mitogenic Activity by Restricting Nuclear Entry of Activated MAPK in Endoderm Differentiation of Embryonic Carcinoma and Stem Cells

Overview
Journal J Cell Biol
Specialty Cell Biology
Date 2004 Feb 26
PMID 14981092
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

In response to retinoic acid, embryonic stem and carcinoma cells undergo differentiation to embryonic primitive endoderm cells, accompanied by a reduction in cell proliferation. Differentiation does not reduce the activation of cellular MAPK/Erk, but does uncouple mitogen-activated protein kinase (MAPK) activation from phosphorylation/activation of Elk-1 and results in inhibition of c-Fos expression, whereas phosphorylation of the cytoplasmic substrate p90RSK remains unaltered. Cell fractionation and confocal immunofluorescence microscopy demonstrated that activated MAPK is restricted to the cytoplasmic compartment after differentiation. An intact actin and microtubule cytoskeleton appears to be required for the restriction of MAPK nuclear entry induced by retinoic acid treatment because the cytoskeletal disrupting agents nocodazole, colchicine, and cytochalasin D are able to revert the suppression of c-Fos expression. Thus, suppression of cell proliferation after retinoic acid-induced endoderm differentiation of embryonic stem and carcinoma cells is achieved by restricting nuclear entry of activated MAPK, and an intact cytoskeleton is required for the restraint.

Citing Articles

Activating mutations remodel the chromatin accessibility landscape to drive distinct regulatory networks in -rearranged acute leukemia.

Zhang Q, Falques-Costa T, Pilheden M, Sturesson H, Ovlund T, Rissler V Hemasphere. 2024; 8(9):e70006.

PMID: 39329074 PMC: 11426354. DOI: 10.1002/hem3.70006.


The cellular microenvironment and cytoskeletal actin dynamics in liver fibrogenesis.

Hijazi N, Rockey D, Shi Z Biocell. 2022; 46(9):2003-2007.

PMID: 35734751 PMC: 9211003. DOI: 10.32604/biocell.2022.020171.


Immunohistochemical staining of phosphorylated-ERK in post-chemotherapeutic samples is a potential predictor of the prognosis of neuroblastoma.

Tanaka T, Togashi Y, Takeuchi Y, Higashi M, Fumino S, Tajiri T Pediatr Surg Int. 2021; 37(2):287-291.

PMID: 33394087 DOI: 10.1007/s00383-020-04806-w.


Retinoic Acid Induces Differentiation of Mouse F9 Embryonic Carcinoma Cell by Modulating the miR-485 Targeting of Abhd2.

Yu M, Zhang L, Liu Y, Liu D, Guo Z Int J Mol Sci. 2019; 20(9).

PMID: 31035455 PMC: 6539702. DOI: 10.3390/ijms20092071.


Regulation of human airway smooth muscle cell migration and relevance to asthma.

Salter B, Pray C, Radford K, Martin J, Nair P Respir Res. 2017; 18(1):156.

PMID: 28814293 PMC: 5559796. DOI: 10.1186/s12931-017-0640-8.


References
1.
Hochholdinger F, Baier G, Nogalo A, Bauer B, Grunicke H, Uberall F . Novel membrane-targeted ERK1 and ERK2 chimeras which act as dominant negative, isotype-specific mitogen-activated protein kinase inhibitors of Ras-Raf-mediated transcriptional activation of c-fos in NIH 3T3 cells. Mol Cell Biol. 1999; 19(12):8052-65. PMC: 84890. DOI: 10.1128/MCB.19.12.8052. View

2.
Whitehurst A, Wilsbacher J, You Y, Luby-Phelps K, Moore M, Cobb M . ERK2 enters the nucleus by a carrier-independent mechanism. Proc Natl Acad Sci U S A. 2002; 99(11):7496-501. PMC: 124259. DOI: 10.1073/pnas.112495999. View

3.
Brondello J, Pouyssegur J, McKenzie F . Reduced MAP kinase phosphatase-1 degradation after p42/p44MAPK-dependent phosphorylation. Science. 2000; 286(5449):2514-7. DOI: 10.1126/science.286.5449.2514. View

4.
Adachi M, Fukuda M, Nishida E . Nuclear export of MAP kinase (ERK) involves a MAP kinase kinase (MEK)-dependent active transport mechanism. J Cell Biol. 2000; 148(5):849-56. PMC: 2174544. DOI: 10.1083/jcb.148.5.849. View

5.
Keyse S . Protein phosphatases and the regulation of mitogen-activated protein kinase signalling. Curr Opin Cell Biol. 2000; 12(2):186-92. DOI: 10.1016/s0955-0674(99)00075-7. View